Rituximab as a possible cause of posterior reversible encephalopathy syndrome

Australasian Medical Journal

Volumn 4, Issue 9, 2011, Pages 513-515

  Siddiqi, Ahmed Imran ^a  

^a East Suffolk and North Essex Foundation Trust   (United Kingdom)

Author keywords

Chemotherapy; Posterior reversible encephalopathy syndrome; Seizures

Indexed keywords

ACICLOVIR; CEPHALOSPORIN; CYCLOPHOSPHAMIDE; DOXORUBICIN; LORAZEPAM; PHENYTOIN; PREDNISOLONE; RITUXIMAB; VINCRISTINE SULFATE;

AGED; ARTICLE; BLURRED VISION; CASE REPORT; COMPUTER ASSISTED TOMOGRAPHY; CONFUSION; EMERGENCY WARD; EPILEPTIC STATE; FEMALE; HEADACHE; HUMAN; MULTIPLE CYCLE TREATMENT; NEUTROPENIA; NONHODGKIN LYMPHOMA; OCCIPITAL LOBE; PAPILLEDEMA; POSTERIOR REVERSIBLE ENCEPHALOPATHY SYNDROME; TONIC CLONIC SEIZURE;

EID: 80355143496     PISSN: None     EISSN: 18361935     Source Type: Journal    
DOI: 10.4066/AMJ.2011.627     Document Type: Article

References (13)

1. Hinchey J, Chaves C, Appignani B, Pao L, Wang A, Pessin MS, Lamy C, Mas JL, Caplan LR. A reversible posterior leukoencephalopathy syndrome. N Engl J Med. 1996;334(8):494-500.
2. Kwon J, Kim S, Kim K, et al. A case of gemcitabine and cisplatin associated posterior reversible encephalopathy syndrome. Cancer Treat Res. 2009 March;41(1): 53-55.
3. Hauser RA, Lacey DM, Knight MR. Hypertensive encephalopathy: magnetic resonance imaging demonstration of reversible cortical and white matter lesions. Arch Neurol. 1988;45(10):1078-1083.
4. Schwartz RB, Jones KM, Kalina P, Bajakian RL, Mantello MT, Garada B, Holman BL. Hypertensive encephalopathy: findings on CT MR imaging, and SPECT imaging in 14 cases. AJR Am J Roentgenol. 1992;159(2):379-383.
5. Trommer BL, Homer D, Mikhael MA. Cerebral vasospasm and eclampsia. Stroke. 1988;19(3):326-329.
6. Dekker GA, Sibai BM. Etiology and pathogenesis of preeclampsia: current concepts. Am J Obstet Gynecol. 1998;179(5):1359-1375.
7. Abenza-Abildua MJ, Fuentes B, Diaz D, Royo A, Olea T, Aguilar-Amat MJ, Diez-Tejedor E. Cyclophosphamide induced reversible posterior leukoencephalopathy syndrome. BMJ Case Rep. 2009;. pii: bcr07.2008.0467.
8. Ay H, Buonanno FS, Schaefer PW, Le DA, Wang B, Gonzalez RG, Koroshetz WJ. Posterior leukoencephalopathy without severe hypertension: utility of diffusion-weighted MRI. Neurology 1998;51(6):1369-1376.
9. Mavragani CP, Vlachoyiannopoulos PG, Kosmas N, Boletis I, Tzioufas AG, Voulgarelis M. A case of reversible posterior leucoencephalopathy syndrome after rituximab infusion. Rheumatology (Oxford). 2004 Nov;43(11):1450-1451.
10. Sánchez-Carteyron A, Alarcia R, Ara JR, Martin J. Posterior reversible encephalopathy syndrome after rituximab infusion in neuromyelitis optica. Neurology. 2010 May 4;74(18):1471-1473
11. Russell MT, Nassif AS, Cacayorin ED, Awwad E, Perman W, Dunphy F. Gemcitabine-associated posterior reversible encephalopathy syndrome: MR imaging and MR spectroscopy findings. Magn Reson Imaging. 2001;19:129-132.
12. Rajasekhar A, George TJ., Jr Gemcitabine-induced reversible posterior leukoencephalopathy syndrome: A case report and review of literature. Oncologist. 2007;12:1332-1335.
13. Ito Y, Arahata Y, Goto Y, Hirayama M, Nagamutsu M, Yasuda T, Yanaqi T, Sobue G. Cisplatin neurotoxicity presenting as reversible posterior leukoencephalopathy syndrome. AJNR Am J Neuroradiol.1998;19:415-417.